This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignees: Evolved by Nature, Inc., Silk Therapeutics, Inc.. Active years: 2015-2024.
Company Filing History:
Years Active: 2015-2024
Title: **Inventor Spotlight: Rachel Lee Dow**
Introduction
Rachel Lee Dow, an accomplished inventor based in Medford, MA, has made significant strides in the field of biotechnology. With a total of 14 patents to her name, she is particularly known for her innovative work with silk fibroin-based protein fragments. Her research and advancements have contributed to the understanding and application of silk proteins in various industries.
Latest Patents
Among her most recent patents, Rachel has developed stable silk protein fragment compositions. These compositions are characterized by their pure silk fibroin-based protein fragments that are largely devoid of sericin. The patents detail that the composition features an average weight average molecular weight ranging from about 17 kDa to about 38 kDa and a polydispersity of between about 1.5 and about 3.0. Importantly, the compositions are designed to be homogeneous, with minimal inorganic and organic residuals, presenting a promising advancement in materials science.
Career Highlights
Throughout her career, Rachel has worked with innovative companies such as Silk Therapeutics, Inc. and Evolved by Nature, Inc. Her contributions have consistently revolved around the applications of silk proteins in health and sustainability, showcasing her commitment to the intersection of technology and nature.
Collaborations
Rachel has collaborated with notable colleagues like Gregory H. Altman and Rachel M. Lind, pooling their expertise to push the boundaries of silk protein research. Their teamwork exemplifies the collaborative spirit prevalent in technological innovation, leading to groundbreaking discoveries and products.
Conclusion
In summary, Rachel Lee Dow stands out as a leading inventor whose work with stable silk protein fragment compositions represents significant advancements in biotechnology. With a robust portfolio of patents and strong collaborations, she continues to impact her field and inspires future innovations within the industry.